Johnson, D H <br/><br/>
Combined-modality therapy for unresectable, stage III non-small-cell lung cancer--caveat emptor or caveat venditor?  [electronic resource] 

 -  Journal of the National Cancer Institute  Sep 1996 
 - 1175-7 p.  digital 
<br/><br/> Publication Type: Comment; Editorial 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/88.17.1175  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Small Cell--drug therapy<br/>Dose-Response Relationship, Drug<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Neoplasm Staging<br/>Radiotherapy Dosage<br/>Survival Analysis<br/>Treatment Outcome